Ischemic Stroke in a Young Man: Unraveling the Domain of Myeloproliferative Disorders

Ischemic stroke is a rare phenomenon in young adults. A complete workup for hypercoagulable and myeloproliferative disorders is a cornerstone of evaluation. Essential thrombocytosis is a chronic myeloproliferative disorder that primarily involves platelets. It may remain undiagnosed in patients and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Curēus (Palo Alto, CA) CA), 2021-07, Vol.13 (7)
Hauptverfasser: Hamid, Muhammad Ammar B, Sehbai, Aasim S, Tariq, Shahan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 7
container_start_page
container_title Curēus (Palo Alto, CA)
container_volume 13
creator Hamid, Muhammad Ammar B
Sehbai, Aasim S
Tariq, Shahan
description Ischemic stroke is a rare phenomenon in young adults. A complete workup for hypercoagulable and myeloproliferative disorders is a cornerstone of evaluation. Essential thrombocytosis is a chronic myeloproliferative disorder that primarily involves platelets. It may remain undiagnosed in patients and subsequently present in the form of ischemic stroke. The management of this disorder is complex and often involves cytoreduction therapies. The initiation of these drugs in such patients may lead to unnecessary adverse effects and complications. This case report is an attempt to highlight an underappreciated cause of stroke when assessing young individuals. 
doi_str_mv 10.7759/cureus.16495
format Article
fullrecord <record><control><sourceid>pubmedcentral_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8373526</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_8373526</sourcerecordid><originalsourceid>FETCH-LOGICAL-c215t-d8e1b6487407f40cb0e9d2b745012fb98c9b4723f998c995f38e06c471cd638c3</originalsourceid><addsrcrecordid>eNpVkMtOwzAQRS0EolXpjg_wB9Bix07ssEBC5VWpFQvogpXlOOPWkMSVnVTq35NShGA1d3RnzuIgdEnJVIg0vzZdgC5Oacbz9AQNE5rJiaSSn_7JAzSO8YMQQolIiCDnaMA4Z4RSMkSreTQbqJ3Br23wn4BdgzV-912zxkvd3OBVE_QOKtfv7Qbwva91f-ItXu6h8tvgK2ch6Nbt-tJFH0oI8QKdWV1FGP_MEVo9PrzNnieLl6f57G4xMQlN20kpgRYZl4ITYTkxBYG8TArBU0ITW-TS5AUXCbP5IeapZRJIZrigpsyYNGyEbo_cbVfUUBpo2qArtQ2u1mGvvHbqf9O4jVr7nZJMsDTJesDVEWCCjzGA_f2lRB0Mq6Nh9W2YfQEjMG-a</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Ischemic Stroke in a Young Man: Unraveling the Domain of Myeloproliferative Disorders</title><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Hamid, Muhammad Ammar B ; Sehbai, Aasim S ; Tariq, Shahan</creator><creatorcontrib>Hamid, Muhammad Ammar B ; Sehbai, Aasim S ; Tariq, Shahan</creatorcontrib><description>Ischemic stroke is a rare phenomenon in young adults. A complete workup for hypercoagulable and myeloproliferative disorders is a cornerstone of evaluation. Essential thrombocytosis is a chronic myeloproliferative disorder that primarily involves platelets. It may remain undiagnosed in patients and subsequently present in the form of ischemic stroke. The management of this disorder is complex and often involves cytoreduction therapies. The initiation of these drugs in such patients may lead to unnecessary adverse effects and complications. This case report is an attempt to highlight an underappreciated cause of stroke when assessing young individuals. </description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.16495</identifier><identifier>PMID: 34430110</identifier><language>eng</language><publisher>Palo Alto (CA): Cureus</publisher><subject>Hematology ; Internal Medicine ; Oncology</subject><ispartof>Curēus (Palo Alto, CA), 2021-07, Vol.13 (7)</ispartof><rights>Copyright © 2021, Hamid et al. 2021 Hamid et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c215t-d8e1b6487407f40cb0e9d2b745012fb98c9b4723f998c995f38e06c471cd638c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373526/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373526/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Hamid, Muhammad Ammar B</creatorcontrib><creatorcontrib>Sehbai, Aasim S</creatorcontrib><creatorcontrib>Tariq, Shahan</creatorcontrib><title>Ischemic Stroke in a Young Man: Unraveling the Domain of Myeloproliferative Disorders</title><title>Curēus (Palo Alto, CA)</title><description>Ischemic stroke is a rare phenomenon in young adults. A complete workup for hypercoagulable and myeloproliferative disorders is a cornerstone of evaluation. Essential thrombocytosis is a chronic myeloproliferative disorder that primarily involves platelets. It may remain undiagnosed in patients and subsequently present in the form of ischemic stroke. The management of this disorder is complex and often involves cytoreduction therapies. The initiation of these drugs in such patients may lead to unnecessary adverse effects and complications. This case report is an attempt to highlight an underappreciated cause of stroke when assessing young individuals. </description><subject>Hematology</subject><subject>Internal Medicine</subject><subject>Oncology</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpVkMtOwzAQRS0EolXpjg_wB9Bix07ssEBC5VWpFQvogpXlOOPWkMSVnVTq35NShGA1d3RnzuIgdEnJVIg0vzZdgC5Oacbz9AQNE5rJiaSSn_7JAzSO8YMQQolIiCDnaMA4Z4RSMkSreTQbqJ3Br23wn4BdgzV-912zxkvd3OBVE_QOKtfv7Qbwva91f-ItXu6h8tvgK2ch6Nbt-tJFH0oI8QKdWV1FGP_MEVo9PrzNnieLl6f57G4xMQlN20kpgRYZl4ITYTkxBYG8TArBU0ITW-TS5AUXCbP5IeapZRJIZrigpsyYNGyEbo_cbVfUUBpo2qArtQ2u1mGvvHbqf9O4jVr7nZJMsDTJesDVEWCCjzGA_f2lRB0Mq6Nh9W2YfQEjMG-a</recordid><startdate>20210719</startdate><enddate>20210719</enddate><creator>Hamid, Muhammad Ammar B</creator><creator>Sehbai, Aasim S</creator><creator>Tariq, Shahan</creator><general>Cureus</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20210719</creationdate><title>Ischemic Stroke in a Young Man: Unraveling the Domain of Myeloproliferative Disorders</title><author>Hamid, Muhammad Ammar B ; Sehbai, Aasim S ; Tariq, Shahan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c215t-d8e1b6487407f40cb0e9d2b745012fb98c9b4723f998c995f38e06c471cd638c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Hematology</topic><topic>Internal Medicine</topic><topic>Oncology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hamid, Muhammad Ammar B</creatorcontrib><creatorcontrib>Sehbai, Aasim S</creatorcontrib><creatorcontrib>Tariq, Shahan</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hamid, Muhammad Ammar B</au><au>Sehbai, Aasim S</au><au>Tariq, Shahan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ischemic Stroke in a Young Man: Unraveling the Domain of Myeloproliferative Disorders</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><date>2021-07-19</date><risdate>2021</risdate><volume>13</volume><issue>7</issue><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Ischemic stroke is a rare phenomenon in young adults. A complete workup for hypercoagulable and myeloproliferative disorders is a cornerstone of evaluation. Essential thrombocytosis is a chronic myeloproliferative disorder that primarily involves platelets. It may remain undiagnosed in patients and subsequently present in the form of ischemic stroke. The management of this disorder is complex and often involves cytoreduction therapies. The initiation of these drugs in such patients may lead to unnecessary adverse effects and complications. This case report is an attempt to highlight an underappreciated cause of stroke when assessing young individuals. </abstract><cop>Palo Alto (CA)</cop><pub>Cureus</pub><pmid>34430110</pmid><doi>10.7759/cureus.16495</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2168-8184
ispartof Curēus (Palo Alto, CA), 2021-07, Vol.13 (7)
issn 2168-8184
2168-8184
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8373526
source PubMed Central; PubMed Central Open Access
subjects Hematology
Internal Medicine
Oncology
title Ischemic Stroke in a Young Man: Unraveling the Domain of Myeloproliferative Disorders
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T17%3A59%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ischemic%20Stroke%20in%20a%20Young%20Man:%20Unraveling%20the%20Domain%20of%20Myeloproliferative%20Disorders&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Hamid,%20Muhammad%20Ammar%20B&rft.date=2021-07-19&rft.volume=13&rft.issue=7&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.16495&rft_dat=%3Cpubmedcentral_cross%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_8373526%3C/pubmedcentral_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/34430110&rfr_iscdi=true